Short interest in GoodRx Holdings Inc (NASDAQ:GDRX) decreased during the last reporting period, falling from 5.74M to 5.05M. This put 5.26% of the company's publicly available shares short.

Truist lowered the firm’s price target on GoodRx (GDRX) to $5.50 from $6.50 and keeps a Hold rating on the shares as part of a broader research note previewing Q1 results in the Healthcare IT ...

GoodRx Holdings, Inc. (Nasdaq: GDRX) (“GoodRx” or the “Company”), the leading platform for medication savings in the U.S., today announced it will release its first quarter 2025 financial ...

GoodRx GDRX recently rolled out a new e-commerce experience aimed at improving how consumers obtain their prescriptions through its platform. This upgraded system offers a more streamlined and ...

Constipation is a digestive symptom that makes passing your stool difficult or painful. It involves straining during bowel movements, having hard or dry stools, and feeling like you haven't ...

Prescription medications specifically for IBS-C: Linaclotide (Linzess) and lubiprostone (Amitiza) increase fluid secretion in the intestines to soften stool and increase bowel movements.

Although, when we looked at GoodRx Holdings (NASDAQ:GDRX), it didn't seem to tick all of these boxes. Trump has pledged to "unleash" American oil and gas and these 15 US stocks have developments ...

If you’ve tried to buy a pack of Pokémon TCG cards in recent times, you’ll already know what a shitshow it’s all become. As we’ve been reporting, the last six months has seen the trading ...